VANCOUVER, British Columbia, Sept. 05, 2023 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, is pleased to announce that Technology Networks Drug Discovery, in its September 1, 2023 issue…

Source

Previous articleCalifornia Psychedelic Decriminalisation Bill Clears Appropriations Committee with Amendments
Next articlePT438 – The Psychedelic Medicine Association and Managing Medical Risk in Patients Seeking Psilocybin Therapy